Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
210028228 210014002 1.6 61 Palliative (P) 2015-07-29 2015-08-03 CARBOPLATIN + VINORELBINE 02 N 210038996 ALEMTUZUMAB + CYCLOPHOSPHAMIDE + METHOTREXATE
210028229 210014003 1.74 null Disease modification (D) 2013-11-12 2013-11-12 MERCAPTOPURINE + METHOTREXATE + VINCRISTINE N N 210039007 UKALL 60+ TRIAL
210028230 210031607 1.75 98 Palliative (P) 2014-11-10 2014-11-16 MERCAPTOPURINE + METHOTREXATE + VINCRISTINE 02 N 210039065 IVAC
210028231 210022732 1.68 82.1 Palliative (P) 2015-11-26 2016-04-15 Nilotinib N N 210039137 ALEMTUZUMAB + CYCLOPHOSPHAMIDE
210028232 210031608 1.75 76 Curative (C) 2015-09-04 2015-09-04 CARBOPLATIN + ETOPOSIDE + VINCRISTINE SULPHATE N N 210039294 DA
210028233 210014007 1.6 91.2 Curative (C) null 2014-05-15 MERCAPTOPURINE + METHOTREXATE + VINCRISTINE N null 210039506 GEMCITABINE + OXALIPLATIN
210028234 210035180 0 50 Disease modification (D) 2017-08-20 2017-08-29 CLOFARABINE + CYCLOPHOSPHAMIDE + ETOPOSIDE N N 210039555 OFATUMUMAB
210028235 210037469 null 77.7 Palliative (P) 2018-11-02 2018-12-21 Capecitabine + Oxaliplatin 21day Y N 210039555 ABVD
210028236 210038653 1.57 6.25 Curative (C) 2016-03-30 2016-04-06 CISPLATIN + ETOPOSIDE N N 210039663 CLARITY TRIAL
210028237 210014013 1.84 88.4 Curative (C) 2017-05-31 2017-06-01 Cytarabine intrathecal 02 null 210040040 MPV
210028238 210014018 null 81.8 Palliative (P) 2016-02-03 2016-04-21 Cyclophosphamide High Dose 2 N 210040051 CLOFARABINE + CYCLOPHOSPHAMIDE + ETOPOSIDE
210028239 210014018 0.99 88.4 Palliative (P) 2017-04-16 2017-04-19 Cytarabine intrathecal N null 210040051 ABVD
210028240 210022736 null 94.9 Curative (C) 2016-03-12 2016-12-15 MELPHALAN N N 210040164 CLARITY TRIAL
210028241 210014020 null 11.4 Curative (C) 2018-01-27 2018-02-27 AML16 DA 3+8 N null 210040298 CYTARABINE HIGH DOSE
210028242 210014023 null 68.6 Curative (C) 2017-05-31 2017-06-04 Cyclophosphamide High Dose N null 210040403 ALEMTUZUMAB + CYCLOPHOSPHAMIDE
210028243 210014025 1.73 81.8 Palliative (P) 2016-05-31 2017-05-02 ALL Int Guide B Int Maint Ph III N N 210040409 DOCETAXEL
210028244 210014029 1.57 25 Adjuvant (A) 2016-06-26 2016-06-26 CARBOPLATIN + ETOPOSIDE + VINCRISTINE SULPHATE 02 N 210040771 R-EPOCH
210028245 210028260 1.66 38.9 Curative (C) 2014-09-01 2014-09-24 MERCAPTOPURINE + METHOTREXATE + VINCRISTINE N N 210040788 RCEOP
210028246 210014032 1.77 78.9 Disease modification (D) 2018-03-22 2018-03-29 Nilotinib N Y 210040826 ABVD
210028247 210014034 1.75 81.7 Disease modification (D) null 2018-07-22 Bexarotene N N 210041159 UKALL2003
210028248 210014037 null 76 Palliative (P) 2018-05-06 2018-05-12 Alemtuzumab + Cyclophos TBI Allo N Y 210041235 CYTARABINE INTRATHECAL
210028249 210014039 null 82 Palliative (P) 2018-02-26 2018-03-01 Cytarabine High Dose N null 210041316 CYTARABINE INTRATHECAL
210028250 210022745 null 76.8 Curative (C) 2016-10-05 2016-10-20 Lenalidomide 25mg (Cycle 1 to 25) Y null 210041453 IBRUTINIB + RITUXIMAB
210028251 210014041 1.73 null Palliative (P) 2015-01-03 2015-10-28 Irinotecan + Temozolomide 02 N 210041453 CLL210 TRIAL
210028252 210014043 1.76 16.5 Palliative (P) 2018-03-29 2018-03-29 CARBOPLATIN + ETOPOSIDE + THIOTEPA null N 210041640 CYCLO + FLUDARABINE + RITUXIMAB
210028253 210014045 1.84 117.5 Palliative (P) 2013-05-30 2013-06-05 Cytarabine intrathecal 02 N 210041720 OFATUMUMAB
210028254 210022748 1.6 49 Curative (C) 2019-02-24 2019-06-17 GEM-P 2 N 210041755 IRINOTECAN + PANITUMUMAB + MDG
210028255 210014050 1.77 16.5 Palliative (P) 2018-04-05 2018-06-01 Packer Maintenance Regimen 02 null 210041781 CLARITY TRIAL
210028256 210014055 0 108.4 Palliative (P) 2015-11-09 2016-11-15 DOCETAXEL + PERTUZUMAB + TRASTUZUMAB 2 N 210042046 UKALL 60+ TRIAL
210028257 210014056 1.79 null Disease modification (D) 2016-01-11 2016-03-27 ALL UKALL2003 C: Ph VII Maintenance N null 210042047 ALEMTUZUMAB + CYCLOPHOSPHAMIDE + METHOTREXATE
210028258 210022756 1.7 81.8 Palliative (P) null 2017-06-27 Ofatumumab Weekly null N 210042061 AML19 TRIAL
210028259 210014060 null null Curative (C) 2016-12-22 2017-01-26 IDARUBICIN N N 210003167 DOCETAXEL + TRASTUZUMAB
210028260 210022759 0 75.6 Curative (C) 2015-01-26 2015-05-10 Pemetrexed N N 210012122 AML18 TRIAL
210028261 210028270 1.59 42.8 Palliative (P) 2018-03-15 2018-06-15 IDARUBICIN 2 N 210022690 CLL210 TRIAL
210028262 210014063 1.68 57.8 Palliative (P) 2018-11-10 2018-11-30 DOCETAXEL + PERTUZUMAB + TRASTUZUMAB null N 210024124 ICE-R
210028263 210014064 1.58 54.7 Adjuvant (A) 2017-12-03 2017-12-06 MITOMYCIN N N 210024514 CYTARABINE
210028264 210014066 0 null Not known (9) null 2017-10-24 Cytarabine HD + Methotrexate HD N N 210025956 ALL CONSOLIDATION
210028265 210014068 1.73 12.2 Palliative (P) 2018-09-10 2018-09-11 CNS LGG Irinotecan & Bevacizumab 2 N 210025987 FLUDARABINE + RITUXIMAB
210028266 210014068 1.72 66.6 Disease modification (D) 2016-11-11 2016-11-12 Cyclophosphamide High Dose N N 210025987 ENZALUTAMIDE
210028267 210033735 0.99 null Curative (C) 2017-06-09 2017-09-08 Bendamustine + Thalidomide +/- Dex N null 210029013 DAUNORUBICIN + VNCRISTINE
210028268 210014069 1.75 null Palliative (P) 2019-08-11 2019-08-11 Irinotecan + Modified De Gramont 2 N 210030920 CLADRIBINE + RITUXIMAB
210028269 210014075 null 81.899 Disease modification (D) 2016-10-21 2016-10-29 Bortezomib +/- Dexamethasone N N 210032826 DA
210028270 210014077 1.62 70.8 Disease modification (D) null 2018-01-31 Melphalan oral null null 210032863 IVAC
210028271 210014079 1.73 0 Curative (C) 2018-01-13 2018-05-08 CNS Medbl Std Risk Maint Cisplatin null N 210033781 IRINOTECAN + MDG
210028272 210028274 1.53 75.4 Disease modification (D) 2017-07-16 2017-07-16 Bevacizumab + NIVOLUMAB 2 N 210034307 DOCETAXEL
210028273 210014084 1.69 75 Palliative (P) 2015-11-16 2016-06-23 Olaparib 02 N 210036972 CARBOPLATIN + PACLITAXEL
210028274 210031622 1.73 70 Curative (C) 2017-05-12 2017-05-12 Obinutuzumab N N 210039936 PILOT TRIAL
210028275 210028278 1.11 92 Curative (C) 2018-01-14 2018-01-15 CLL210 TRIAL N N 210040141 IDARUBICIN
210028276 210022776 1.72 77.5 Not known (9) null 2017-01-26 Cytarabine intrathecal N N 210041480 CYCLOPHOSPHAMIDE + ETOPOSIDE + NELARABINE
210028277 210014088 1.78 55.6 Adjuvant (A) 2019-03-17 2019-04-14 Trastuzumab emtansine (Kadcyla) 1st 02 N 210041640 R CODOX-M/ R IVAC